Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists

By sjmartinez • November 24, 2024

Rastogi A, Chertow GM, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P. Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists. Adv Kidney Dis Health. 2024 Nov;31(6):514-522. doi: 10.1053/j.akdh.2024.08.003. PMID: 39577885.

Tags: Chronic kidney disease, consensus, Hyperkalemia, Nephrology, Potassium binder, Publications, sodium zirconium cyclosilicate

The Trojan Horse of Kidney Transplantation Returns: A Review and Call for Financial Neutrality

Danovitch GM. The Trojan Horse of Kidney Transplantation Returns: A Review and Call for Financial Neutrality. Clin J Am Soc Nephrol. 2024 Nov 22. doi:[...]

Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode

Pollack CV Jr, Arroyo D, Kanda E, Lázaro IJS, Lesén E, Franzén S, Gray CM, Lipińska A, Murohara T, Rastogi A. Duration of sodium zirconium[...]

Advancing Equitable Kidney Care through Population Health Approaches in Los Angeles County’s Safety Net System

Kalantar-Zadeh K, Raff EA, Chong CC, Yang JK, Le TK, Barba LM, Pham PC, Dhamija R, Ghaffari A, Khine A, Patel N, Nicholas SB, Sim[...]